PEN.NYSEPenumbra INC

Form 4: Penumbra Inc. CEO Adam Elsesser Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Penumbra Inc.'s CEO, Adam Elsesser, exercised stock options and sold shares on April 16, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • On April 16, 2025, Adam Elsesser, the CEO and President of Penumbra Inc., executed a stock option for 27,976 shares at a price of $30.
  • Simultaneously, Elsesser sold a total of 20,551 shares of common stock at prices ranging from $271.88 to $277.3 per share.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which was established in connection with the expiration of certain stock options and to cover the exercise price and tax obligations.
  • Following these transactions, Elsesser directly owns 63,911 shares and indirectly owns 837,582 shares through a trust.
  • The sales were executed in multiple trades, with weighted average prices reported for each set of transactions.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of key executives and their potential alignment with shareholder interests. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

  • Insider trading activity is a common occurrence in publicly listed companies, and the reporting requirements are standardized by the SEC.
  • Comparable companies such as Medtronic, Boston Scientific, and Abbott also have executives who regularly file Form 4s to report their transactions.
  • The use of 10b5-1 trading plans is a widely accepted practice among executives to manage their stock holdings while avoiding potential conflicts of interest.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
  • The use of a 10b5-1 trading plan ensures transparency and reduces the risk of insider trading, which benefits all stakeholders.

Key Dates

DateDescription
04/16/2025Date of stock option exercise and share sales.
04/18/2025Date of signature on the Form 4 filing.
09/16/2025Expiration date of the stock options.

Keywords

Form 4, Penumbra Inc, Adam Elsesser, Stock Options, Share Sales, Rule 10b5-1, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.